Dr. Bharat Gupta, MD

NPI: 1992749410
Total Payments
$127,168
2024 Payments
$664.29
Companies
31
Transactions
1,079
Medicare Patients
1,293
Medicare Billing
$136,086

Payment Breakdown by Category

Other$87,019 (68.4%)
Food & Beverage$31,210 (24.5%)
Travel$6,834 (5.4%)
Consulting$1,926 (1.5%)
Education$179.22 (0.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $87,019 57 68.4%
Food and Beverage $31,210 932 24.5%
Travel and Lodging $6,834 57 5.4%
Consulting Fee $1,926 2 1.5%
Education $179.22 31 0.1%

Top Paying Companies

Company Total Records Latest Year
SANOFI-AVENTIS U.S. LLC $55,042 140 $0 (2022)
Janssen Pharmaceuticals, Inc $48,913 147 $0 (2022)
Amgen Inc. $5,222 67 $0 (2024)
PFIZER INC. $3,141 172 $0 (2023)
GlaxoSmithKline, LLC. $2,554 121 $0 (2023)
AstraZeneca Pharmaceuticals LP $1,842 33 $0 (2023)
Novo Nordisk Inc $1,710 81 $0 (2023)
ABBVIE INC. $1,455 61 $0 (2024)
Amarin Pharma Inc. $1,333 34 $0 (2021)
Lilly USA, LLC $935.24 88 $0 (2021)

Payment History by Year

Year Amount Transactions Top Company
2024 $664.29 6 Amgen Inc. ($374.97)
2023 $1,908 44 Amgen Inc. ($798.47)
2022 $2,390 78 Amgen Inc. ($866.80)
2021 $3,977 165 Amgen Inc. ($766.84)
2020 $2,939 112 GlaxoSmithKline, LLC. ($448.29)
2019 $19,652 193 Janssen Pharmaceuticals, Inc ($12,784)
2018 $34,843 184 SANOFI-AVENTIS U.S. LLC ($20,421)
2017 $60,794 297 SANOFI-AVENTIS U.S. LLC ($31,705)

All Payment Transactions

1,079 individual payment records from CMS Open Payments — Page 1 of 44

Date Company Product Nature Form Amount Type
09/10/2024 ABBVIE INC. QULIPTA (Drug), UBRELVY Food and Beverage In-kind items and services $65.22 General
Category: NEUROSCIENCE
08/26/2024 Amgen Inc. Otezla (Drug) Food and Beverage In-kind items and services $124.99 General
Category: Inflammation
08/15/2024 ABBVIE INC. QULIPTA (Drug) Food and Beverage In-kind items and services $112.49 General
Category: NEUROSCIENCE
07/31/2024 Braeburn Inc. BRIXADI (Drug) Food and Beverage Cash or cash equivalent $111.61 General
Category: Opioid Use Disorder
05/15/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $124.99 General
Category: Cardiology
04/17/2024 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $124.99 General
Category: Cardiology
12/11/2023 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $124.99 General
Category: Cardiology
12/11/2023 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $28.37 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
12/06/2023 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $3.47 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
10/24/2023 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $5.83 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
09/18/2023 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $124.99 General
Category: Cardiology
09/15/2023 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $5.94 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
08/30/2023 GlaxoSmithKline, LLC. AREXVY (Drug) Food and Beverage In-kind items and services $112.85 General
Category: RESPIRATORY
08/22/2023 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $10.17 General
Category: RESPIRATORY
08/16/2023 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $3.19 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
08/15/2023 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $14.70 General
Category: Inflammation
08/14/2023 Amgen Inc. Otezla (Drug) Food and Beverage In-kind items and services $124.99 General
Category: Inflammation
08/03/2023 ABBVIE INC. UBRELVY (Drug) Food and Beverage In-kind items and services $23.31 General
Category: NEUROSCIENCE
07/17/2023 Novo Nordisk Inc Rybelsus (Drug), Ozempic Food and Beverage In-kind items and services $23.07 General
Category: Diabetes
07/14/2023 PFIZER INC. ELIQUIS (Drug) Food and Beverage In-kind items and services $16.47 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
07/10/2023 Amgen Inc. Otezla (Drug), Repatha Food and Beverage In-kind items and services $9.93 General
Category: Inflammation
06/26/2023 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $124.99 General
Category: Cardiology
06/21/2023 PFIZER INC. ELIQUIS (Drug), PAXLOVID, NURTEC ODT Food and Beverage In-kind items and services $9.27 General
Category: CARDIOVASCULAR;METABOLIC DISEASE
06/20/2023 GlaxoSmithKline, LLC. TRELEGY ELLIPTA (Drug) Food and Beverage In-kind items and services $10.00 General
Category: RESPIRATORY
06/05/2023 Amgen Inc. Repatha (Biological) Food and Beverage In-kind items and services $124.99 General
Category: Cardiology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 2 160 302 $82,649 $16,122
2022 5 261 493 $99,147 $32,806
2021 5 360 666 $113,032 $42,054
2020 10 512 872 $137,021 $45,104
Total Patients
1,293
Total Services
2,333
Medicare Billing
$136,086
Procedure Codes
22

All Medicare Procedures & Services

22 procedure records from CMS Medicare Utilization

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 116 247 $70,507 $13,707 19.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 44 55 $12,143 $2,415 19.9%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 126 333 $65,429 $21,552 32.9%
99215 Established patient office or other outpatient visit, 40-54 minutes Office 2022 61 80 $18,781 $6,199 33.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 41 47 $6,242 $1,850 29.6%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 20 20 $5,279 $1,726 32.7%
99495 Transitional care management services for problem of moderate complexity Office 2022 13 13 $3,416 $1,479 43.3%
99214 Established patient outpatient visit, total time 30-39 minutes Office 2021 168 395 $67,940 $25,326 37.3%
99215 Established patient outpatient visit, total time 40-54 minutes Office 2021 59 93 $21,568 $10,144 47.0%
99213 Established patient outpatient visit, total time 20-29 minutes Office 2021 75 109 $13,708 $4,708 34.3%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Office 2021 28 37 $4,313 $1,150 26.7%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Office 2021 30 32 $5,504 $725.17 13.2%
99214 Established patient office or other outpatient, visit typically 25 minutes Office 2020 142 276 $47,472 $12,928 27.2%
99443 Physician telephone patient service, 21-30 minutes of medical discussion Office 2020 109 158 $27,176 $9,205 33.9%
99233 Subsequent hospital inpatient care, typically 35 minutes per day Facility 2020 19 93 $15,639 $7,695 49.2%
99213 Established patient office or other outpatient visit, typically 15 minutes Office 2020 90 132 $15,387 $3,758 24.4%
99442 Physician telephone patient service, 11-20 minutes of medical discussion Office 2020 61 87 $10,142 $3,250 32.0%
99232 Subsequent hospital inpatient care, typically 25 minutes per day Facility 2020 12 40 $4,664 $2,289 49.1%
99215 Established patient office or other outpatient, visit typically 40 minutes Office 2020 32 32 $7,421 $2,114 28.5%
99223 Initial hospital inpatient care, typically 70 minutes per day Facility 2020 11 14 $4,584 $2,029 44.3%
99239 Hospital discharge day management, more than 30 minutes Facility 2020 16 20 $3,462 $1,701 49.1%
G2012 Brief communication technology-based service, e.g. virtual check-in, by a physician or other qualified health care professional who can report evaluation and management services, provided to an established patient, not originating from a related e/m servic Office 2020 20 20 $1,075 $135.12 12.6%

About Dr. Bharat Gupta, MD

Dr. Bharat Gupta, MD is a Internal Medicine healthcare provider based in Rochester, New York. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1992749410.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Bharat Gupta, MD has received a total of $127,168 in payments from pharmaceutical and medical device companies, with $664.29 received in 2024. These payments were reported across 1,079 transactions from 31 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($87,019).

As a Medicare-enrolled provider, Gupta has provided services to 1,293 Medicare beneficiaries, totaling 2,333 services with total Medicare billing of $136,086. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.

Practice Information

  • Specialty Internal Medicine
  • Location Rochester, NY
  • Active Since 06/15/2006
  • Last Updated 12/23/2015
  • Taxonomy Code 207R00000X
  • Entity Type Individual
  • NPI Number 1992749410

Products in Payments

  • XARELTO (Drug) $39,836
  • SOLIQUA (Drug) $32,823
  • TOUJEO (Drug) $19,231
  • INVOKANA (Drug) $8,851
  • Repatha (Biological) $2,348
  • ELIQUIS (Drug) $2,334
  • DISEASE STATE (Drug) $2,034
  • TRELEGY ELLIPTA (Drug) $1,623
  • Vascepa (Drug) $1,333
  • FARXIGA (Drug) $1,164
  • Otezla (Drug) $1,088
  • ENTRESTO (Drug) $887.97
  • Prolia (Biological) $855.95
  • CHANTIX (Drug) $854.64
  • UBRELVY (Drug) $781.56
  • Aimovig (Biological) $774.23
  • EUCRISA (Drug) $706.41
  • Ozempic (Drug) $678.40
  • TRULICITY (Drug) $589.06
  • UTIBRON (Drug) $495.39

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Internal Medicine Doctors in Rochester